[Liver and kidney function following oral administration of the anti-androgen cyproteron-acetate].
D000284:Administration, Oral; D000410:Alanine Transaminase / Q000097:blood; D000726:Androgen Antagonists; D001219:Aspartate Aminotransferases / Q000097:blood; D001663:Bilirubin / Q000097:blood; D001806:Blood Urea Nitrogen; D002986:Clinical Trials as Topic; D003404:Creatinine / Q000097:blood / Q000652:urine; D003534:Cyproterone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007668:Kidney / Q000187:drug effects*; D008099:Liver / Q000187:drug effects*; D008297:Male; D008875:Middle Aged; D010088:Oxidoreductases / Q000097:blood; D011245:Pregnadienes / Q000009:adverse effects*; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D013012:Sorbitol; D013448:Sulfobromophthalein / Q000097:blood; D013943:Thymol / Q000097:blood
D000726:Androgen Antagonists; D011245:Pregnadienes; D013448:Sulfobromophthalein; D013943:Thymol; D013012:Sorbitol; D003404:Creatinine; D003534:Cyproterone; D010088:Oxidoreductases; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D001663:Bilirubin
Leber- und Nierenfunktion nach oraler Gabe des Antiandrogens cyproteron-acetat.